Sinopharm Group Zhaoqing Co., Ltd announced that it will receive CNY 25,000,000 on April 19, 2017.The transaction will include participation from existing investor China National Accord Medicines Corporation Ltd. (SZSE:000028) on April 19, 2017. Post the closing the registered capital of the company will increase from CNY 15,000,000 to CNY 40,000,000 and the investor will retain its 100% stake in the company. The transaction has been approved at the 22nd meeting of the 7th directorate of the investor and is not subject to shareholders’ approval of the investor. The company reported total assets of CNY 147,620,000, net assets of CNY 19,260,000, and revenue of CNY 199,910,000 for the year ended December 31, 2016.